429 related articles for article (PubMed ID: 15701438)
1. Heart transplant and left ventricular assist device costs.
Digiorgi PL; Reel MS; Thornton B; Burton E; Naka Y; Oz MC
J Heart Lung Transplant; 2005 Feb; 24(2):200-4. PubMed ID: 15701438
[TBL] [Abstract][Full Text] [Related]
2. Costs and reimbursement gaps after implementation of third-generation left ventricular assist devices.
Mishra V; Geiran O; Fiane AE; Sørensen G; Andresen S; Olsen EK; Khushi I; Hagen TP
J Heart Lung Transplant; 2010 Jan; 29(1):72-8. PubMed ID: 19783175
[TBL] [Abstract][Full Text] [Related]
3. Hospital costs for left ventricular assist devices for destination therapy: lower costs for implantation in the post-REMATCH era.
Miller LW; Nelson KE; Bostic RR; Tong K; Slaughter MS; Long JW
J Heart Lung Transplant; 2006 Jul; 25(7):778-84. PubMed ID: 16818120
[TBL] [Abstract][Full Text] [Related]
4. Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure.
Dang NC; Topkara VK; Mercando M; Kay J; Kruger KH; Aboodi MS; Oz MC; Naka Y
J Heart Lung Transplant; 2006 Jan; 25(1):1-6. PubMed ID: 16399523
[TBL] [Abstract][Full Text] [Related]
5. Relationship of nutritional status to length of stay, hospital costs, and discharge status of patients hospitalized in the medicine service.
Chima CS; Barco K; Dewitt ML; Maeda M; Teran JC; Mullen KD
J Am Diet Assoc; 1997 Sep; 97(9):975-8; quiz 979-80. PubMed ID: 9284874
[TBL] [Abstract][Full Text] [Related]
6. Evolving costs of long-term left ventricular assist device implantation.
Gelijns AC; Richards AF; Williams DL; Oz MC; Oliveira J; Moskowitz AJ
Ann Thorac Surg; 1997 Nov; 64(5):1312-9. PubMed ID: 9386696
[TBL] [Abstract][Full Text] [Related]
7. Temporal changes in hospital costs for left ventricular assist device implantation.
Slaughter MS; Bostic R; Tong K; Russo M; Rogers JG
J Card Surg; 2011 Sep; 26(5):535-41. PubMed ID: 21848578
[TBL] [Abstract][Full Text] [Related]
8. Multidisciplinary approach decreases length of stay and reduces cost for ventricular assist device therapy.
Murray MA; Osaki S; Edwards NM; Johnson MR; Bobadilla JL; Gordon EA; Sanderfoot M; Kohmoto T
Interact Cardiovasc Thorac Surg; 2009 Jan; 8(1):84-8. PubMed ID: 18940829
[TBL] [Abstract][Full Text] [Related]
9. Comparative survival and cost-effectiveness of advanced therapies for end-stage heart failure.
Long EF; Swain GW; Mangi AA
Circ Heart Fail; 2014 May; 7(3):470-8. PubMed ID: 24563450
[TBL] [Abstract][Full Text] [Related]
10. Does continuous flow left ventricular assist device technology have a positive impact on outcome pretransplant and posttransplant?
Klotz S; Stypmann J; Welp H; Schmid C; Drees G; Rukosujew A; Scheld HH
Ann Thorac Surg; 2006 Nov; 82(5):1774-8. PubMed ID: 17062246
[TBL] [Abstract][Full Text] [Related]
11. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
[TBL] [Abstract][Full Text] [Related]
12. Surgical ventricular restoration versus cardiac transplantation: a comparison of cost, outcomes, and survival.
Williams JA; Weiss ES; Patel ND; Nwakanma LU; Reeb BE; Conte JV
J Card Fail; 2008 Sep; 14(7):547-54. PubMed ID: 18722319
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness analysis of continuous-flow left ventricular assist devices as destination therapy.
Rogers JG; Bostic RR; Tong KB; Adamson R; Russo M; Slaughter MS
Circ Heart Fail; 2012 Jan; 5(1):10-6. PubMed ID: 22052901
[TBL] [Abstract][Full Text] [Related]
14. End-organ function in patients on long-term circulatory support with continuous- or pulsatile-flow assist devices.
Radovancevic B; Vrtovec B; de Kort E; Radovancevic R; Gregoric ID; Frazier OH
J Heart Lung Transplant; 2007 Aug; 26(8):815-8. PubMed ID: 17692785
[TBL] [Abstract][Full Text] [Related]
15. Right heart failure and "failure to thrive" after left ventricular assist device: clinical predictors and outcomes.
Baumwol J; Macdonald PS; Keogh AM; Kotlyar E; Spratt P; Jansz P; Hayward CS
J Heart Lung Transplant; 2011 Aug; 30(8):888-95. PubMed ID: 21530314
[TBL] [Abstract][Full Text] [Related]
16. Effect of left ventricular assist device infection on post-transplant outcomes.
Schulman AR; Martens TP; Russo MJ; Christos PJ; Gordon RJ; Lowy FD; Oz MC; Naka Y
J Heart Lung Transplant; 2009 Mar; 28(3):237-42. PubMed ID: 19285614
[TBL] [Abstract][Full Text] [Related]
17. Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices.
Patel ND; Weiss ES; Schaffer J; Ullrich SL; Rivard DC; Shah AS; Russell SD; Conte JV
Ann Thorac Surg; 2008 Sep; 86(3):832-40; discussion 832-40. PubMed ID: 18721570
[TBL] [Abstract][Full Text] [Related]
18. Costs associated with ventricular assist device use in children.
Mahle WT; Ianucci G; Vincent RN; Kanter KR
Ann Thorac Surg; 2008 Nov; 86(5):1592-7. PubMed ID: 19049755
[TBL] [Abstract][Full Text] [Related]
19. Improved survival after heart transplantation in patients with bridge to transplant in the recent era: a 17-year single-center experience.
Osaki S; Edwards NM; Johnson MR; Velez M; Munoz A; Lozonschi L; Murray MA; Proebstle AK; Kohmoto T
J Heart Lung Transplant; 2009 Jun; 28(6):591-7. PubMed ID: 19481020
[TBL] [Abstract][Full Text] [Related]
20. A hospital perspective on the cost-effectiveness of beta-blockade for prophylaxis of atrial fibrillation after cardiothoracic surgery.
Gillespie EL; White CM; Kluger J; Sahni J; Gallagher R; Coleman CI
Clin Ther; 2005 Dec; 27(12):1963-9. PubMed ID: 16507383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
